Genética, Genómica y COVID-19: implicaciones éticas
Palabras clave:
genética, genómica, hospedero, COVID-19, éticaResumen
Introducción:
La genética y la genómica contribuyen al desarrollo de enfoques personalizados y más efectivos para la prevención y el tratamiento de enfermedades infecciosas. Durante la actual pandemia se realizan estudios genómicos a pacientes con COVID-19 o expuestos no afectados, para delinear los factores del huésped asociados con la variabilidad en la susceptibilidad, la infectividad y gravedad de la enfermedad.
Objetivo:
Describir las implicaciones éticas de la genética y genómica en la práctica clínica y la salud pública durante la pandemia de la COVID-19.
Métodos:
Se consultan las bases bibliográficas de PubMed/Medline y Google académico. Se describen las implicaciones éticas, beneficios y perjuicios relacionados con los estudios genéticos y genómicos, en la práctica clínica y la salud pública en la COVID-19.
Conclusiones:
Los estudios genéticos y genómicos desarrollados durante la pandemia de COVID-19 representan un logro de la coordinación y cooperación global.
Descargas
Citas
Organización Mundial de la Salud. Coronavirus Disease (COVID-19) Dashboard. Data last updated: 2020/11/27 [Internet]. Ginebra: OMS; 2020 [citado 27 nov 2020]. Disponible en: https://covid19.who.int/
Ministerio de Salud Pública de Cuba. Informe epidemiológico COVID-19, 27/11/2020. [citado 27 nov 2020]. Disponible en: https://salud.msp.gob.cu/
Liu Y, Häussinger L, Steinacker JM, Dinse-Lambracht A. Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution. Epidemiol Infect[Internet]. 2021 Jan 7[citado 13 Dic 2021];149:e19. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844181/
American Association for the Advancement of Science[Internet]. Washington, DC: American Association for the Advancement of Science; © 2021. How sick will the coronavirus make you? The answer may be in your genes. [citado 13 Dic 2021]. Disponible en: https://www.science.org/content/article/how-sick-will-coronavirus-make-you-answer-may-be-your-genes
Genetics Initiative . The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet[Internet]. 2020[citado 13 Dic 2021];28(6):715–8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220587/
Solomon I, Harrington E, Hooker G, Erby L, Axilbund J, Hampel H, et al. Lynch syndrome limbo: patient understanding of variants of uncertain significance. J Genet Couns[Internet]. 2017[citado 13 Dic 2021];26(4):866–77. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1007/s10897-017-0066-y
Brabbing Goldstein D, Reches A, Svirsky R, Bar Shira A, Yaron Y. Dilemmas in genetic counseling for low-penetrance neuro-susceptibility loci detected on prenatal chromosomal microarray analysis. Am J Obstet Gynecol[Internet]. 2018[citado 13 Dic 2021];218(2): 247.e1-247.e12. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0002937817323244?via%3Dihub
Brothers KB, Rothstein MA. Ethical, legal and social implications of incorporating personalized medicine into healthcare. Per Med[Internet]. 2015[citado 13 Dic 2021];12(1):43-51. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296905/
Boyce AM, Garibaldi BT. Genomics and high-consequence infectious diseases: a scoping review of emerging science and potential ethical issues. Health Secur[Internet]. 2019 Jan/Feb[citado 13 Dic 2021];17(1):62-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424158/
Walker A, Boyce A, Duggal P, Thio CL, Geller G. Genomics and infectious diseases: expert perspectives on public health considerations regarding actionability and privacy. Ethics Hum Res[Internet]. 2020 May[citado 13 Dic 2021];42(3):30-40. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/eahr.500051
Kuo C-L, Pilling LC, Atkins JL, Masoli J, Delgado J, Kuchel GA,et al. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci[Internet]. 2020[citado 13 Dic 2021]; 75(11): 2231–2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314139/pdf/glaa131.pdf
Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell[Internet]. 2019[citado 13 Dic 2021];177(1):26–31. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380073/
Mills MC, Rahal C. The GWAS Diversity Monitor tracks diversity by disease in real time. Nat Genet[Internet]. 2020[citado 13 Dic 2021];52(3):242–3. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/32139905
Milne R. Societal considerations in host genome testing for COVID-19. Genet Med[Internet]. 2020[citado 13 Dic 2021]; 22:1464–6. Disponible en: https://www.nature.com/articles/s41436-020-0861-y.pdf
Greninger AL. Societal implications of the internet of pathogens. J Clin Microbiol[Internet]. 2019[citado 13 Dic 2021];57(6):e01914–e18. Disponible en: https://journals.asm.org/doi/epub/10.1128/JCM.01914-18
Walker A, Boyce A, Geller G, Thio CL, Kahn JP. Direct-acting antivirals and hepatitis C: the ethics of price and rationing by genotype. Clin Infect Dis[Internet]. 2018[citado 13 Dic 2021];67(6):983–4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190899/
US Equal Employment Opportunity Commission[Internet]. Washington, DC: US Equal Employment Opportunity Commission; c2020. What you should know about COVID-19 and the ADA, the Rehabilitation Act, and other EEO laws. [citado 13 Dic 2021]. Disponible en: https://www.eeoc.gov/wysk/what-you-should-know-about-covid-19-and-ada-rehabilitation-act-and-other-eeo-laws
Bentley AR, Callier SL, Rotimi CN. Evaluating the promise of inclusion of African ancestry populations in genomics. npj Genom Med[Internet]. 2020[citado 13 Dic 2021];5(5):1–9. Disponible en: https://www.nature.com/articles/s41525-019-0111-x.pdf
Valdés Fernández BN, Duconge J, Espino AM, Ruaño G. Personalized health and the coronavirus vaccines-Do individual genetics matter? Bioessays[Internet]. 2021 Sep[citado 13 Dic 2021];43(9):e2100087. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/bies.202100087
Molster CM, Bowman FL, Bilkey GA, Cho AS, Burns BL, Nowak KJ, Dawkins HJS. The Evolution of Public Health Genomics: Exploring Its Past, Present, and Future. Front Public Health[Internet]. 2018 Sep 4[citado 13 Dic 2021];6:247. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131666/
Lantos JD. Ethical and Psychosocial Issues in Whole Genome Sequencing (WGS) for Newborns. Pediatrics[Internet]. 2019 Jan[citado 13 Dic 2021];143(Suppl 1):S1-S5.Disponible en: https://publications.aap.org/pediatrics/article/143/Supplement_1/S1/34201/Ethical-and-Psychosocial-Issues-in-Whole-Genome
Mackley MP, Fletcher B, Parker M, Watkins H, Ormondroyd E. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. Genet Med[Internet]. 2017 Mar[citado 13 Dic 2021];19(3):283-93.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447864/pdf/gim2016109a.pdf
Martinez-Martin N, Magnus D. Privacy and ethical challenges in next-generation sequencing. Expert Rev Precis Med Drug Dev[Internet]. 2019[citado 13 Dic 2021];4(2):95-104. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413244/
Kost RG, Poppel SM, Coller BS. Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators. J Clin Transl Sci[Internet]. 2017 Apr[citado 13 Dic 2021];1(2):115-120. Disponible en: https://www.cambridge.org/core/journals/journal-of-clinical-and-translational-science/article/informed-consent-for-nextgeneration-nucleotide-sequencing-studies-aiding-communication-between-participants-and-investigators/2B0293050882D3F0A240726367293B13
Marchant G, Barnes M, Evans JP, LeRoy B, Wolf SM, Law Seq Liability Task Force. From genetics to genomics: facing the liability implications in clinical care. J Law Med Ethics[Internet]. 2020 Mar;48(1):11-43. Disponible en: https://journals.sagepub.com/doi/full/10.1177/1073110520916994
Coller BS. Ethics of human genome editing. Annu Rev Med[Internet]. 2019 Jan 27;70:289-305. Disponible en: https://doi:10.1146/annurev-med-112717-094629
Geller G, Duggal P, Thio CL, Mathews D, Kahn JP, Maragakis LL, et al. Genomics in the era of COVID-19: ethical implications for clinical practice and public health. Genome Med[Internet]. 2020 Nov[citado 25 Abr 2021];12(1):95. Disponible en: https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-020-00792-9
Kumar S, Jha S, Rai SK. Significance of super spreader events in COVID-19. Indian J Public Health[Internet]. 2020 Jun[citado 25 Abr 2021]; 64(Suppl 2):S139-S141. Disponible en: https://www.ijph.in/temp/IndianJPublicHealth646139-6531668_180836.pdf
Rotimi CN, Marshall PA. Tailoring the process of informed consent in genetic and genomic research. Genome Med[Internet]. 2010 [citado 25 Abr 2021];2:20. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873798/
Fariñas Acosta L. Cuba en busca del riesgo genético ante la COVID-19 [Internet]. Cubadebate. La Habana: UCI; © 2014 [actualizado 3 Nov 2020; citado 25 Abr 2021]. Disponible en: http://www.cubadebate.cu/especiales/2020/11/03/cuba-en-busca-del-riesgo-genetico-ante-la-covid-19/
